Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacology of 6-thioguanine in man.

× No keyword cloud information.

21 in total

1. Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma.

Authors: F V Fossella; R J Winn; P Y Holoye; M N Raber; L Holden; R Belt; H Allen; B Hallinan; K Harper
Journal: Invest New Drugs Date: 1991-11 Impact factor: 3.850

Review 2. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

Review 3. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors: A G Bosanquet
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

4. Absence of demonstrable linkage of human genes for enzymes of the purine and pyrimidine salvage pathways in human-mouse somatic cell hybrids.

Authors: C Long; T Chan; V Levytska; T Kusano; H Green
Journal: Biochem Genet Date: 1973-07 Impact factor: 1.890

5. 6-Thioguanine: high-dose 2-H infusions in goats.

Authors: T J Schouten; R A De Abreu; E D Schretlen; M B van Leeuwen; J M van Baal; G A de Vaan
Journal: J Cancer Res Clin Oncol Date: 1985 Impact factor: 4.553

6. Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.

Authors: J A Ajani; R Pazdur; R J Winn; J L Abbruzzese; B Levin; C Wiseman; M A Lenado-Lee; Y Z Patt; I H Krakoff
Journal: Invest New Drugs Date: 1991-08 Impact factor: 3.850

7. Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer. A Southwest Oncology Group study.

Authors: S K Williamson; J Crowley; R B Livingston; G Weiss
Journal: Invest New Drugs Date: 1993-02 Impact factor: 3.850

Pharmacology of 6-thioguanine in man.